Cancer Matters

Cancer Matters with Dr. Bill Nelson – The Checkmate 816 Trial

April 11, 2022

In the latest Cancer Matters podcast, Dr Bill Nelson speaks with Dr Patrick Forde about the results of a clinical trial that show pairing immunotherapy treatments with chemotherapy greatly increases survival in patients with lung cancer. Learn more about the Checkmate-816 Trial here. Read more about the impact of the study here.

cpetty7 ⋅ Bill Nelson, Checkmate-816 Trial, Chemotherapy, immunotherapy, Johns Hopkins Kimmel Cancer Center, lung cancer, Patrick Forde, podcast ⋅

On Target with Dr. Akila Viswanathan – Global Health Catalyst

November 16, 2021

Dr Akila Viswanathan talks with Dr Wilfred Ngwa about both his work as the Director of the Global Health Catalyst, which aims to reduce cancer health disparities around the world, and his research pairing medical physics with immunotherapy. Learn more at globalhealthcatalystsummit.org  

cpetty7 ⋅ Akila Viswanathan, Global Health Catalyst, immunotherapy, Johns Hopkins Kimmel Cancer Center, On Target, Physics, podcast ⋅

Cancer Matters with Dr. Bill Nelson – AstroPath

August 26, 2021

In the latest Cancer Matters podcast, Dr Bill Nelson talks with Dr Janis Taube and Dr Alex Szalay about AstroPath, a new platform that combines astronomy with pathology to identify predictive biomarkers for cancer immunotherapy.          

cpetty7 ⋅ Alex Szalay, Astronomy, AstroPath, immunotherapy, Janis Taube, Johns Hopkins Kimmel Cancer Center, pathology, podcast ⋅

New Advances in Therapies: Five-Drug Combo

November 19, 2020

Arnold’s advanced pancreas cancer that had spread to his liver was eliminated with a low-dose, five-drug combination being studied in a clinical trial led by Dung Le. Le is now testing new iterations of the therapy to see if she can help more patients. A new drug cocktail adds immunotherapy and a PARP inhibitor to […]

cpetty7 ⋅ Bloomberg~Kimmel Institute For Cancer Immunotherapy, Dung Le, immunotherapy, Johns Hopkins Kimmel Cancer Center, Karim Boudadi, Lustgarten Foundation, Michael Pishvaian, Nilofer Azad, PARP, precision medicine, Research, Swim Across America, treatment ⋅

Immune Cells Hampered When Fighting Soft Tissue and Bone Sarcomas

June 25, 2020

Researchers at the Johns Hopkins Kimmel Cancer Center are studying the immune system to find what does and doesn't work to better fight soft tissue & bone cancer. “The basis of successful immunotherapy lies in the ability of the immune system to recognize cancer as foreign and attack, and is dependent on genetics, host and […]

Clinton ⋅ Issues & Perspectives bone, immunotherapy, Johns Hopkins Kimmel Cancer Center, Nicolas Llosa, sarcoma, soft tissue, treatment ⋅

OSONDU: The Race for Life (Part 3)

January 13, 2020

Clement Okoh is a cancer survivor, author, entrepreneur….and proud grandfather. Cancer Matters is sharing book excerpts of his personal journey, “OSONDU,", an inspiring story of hope. Photo: Me with RN's Michaella Iacoboni and Manny Bravo. Read part 1 here: PART 1, PART 2 -- OSONDU – Agency, Hope and Survival (part 3) It’s nearly impossible […]

Clinton ⋅ Patient Stories CAR T-cell, Clement Okoh, immunotherapy, Johns Hopkins Kimmel Cancer Center, Multiple Myeloma, OSONDU, Race For Life ⋅

Cancer Matters with Dr. Bill Nelson – Advances in Lung Cancer

December 26, 2019

In this Cancer Matters podcast, Dr Bill Nelson talks with Dr Julie Brahmer about the advances made in treating patients with lung cancer, smoking cessation and lung cancer screening.

Clinton ⋅ Bill Nelson, Cancer Matters, immunotherapy, Johns Hopkins Kimmel Cancer Center, Julie Brahmer, lung cancer, podcast, screening, Smoking Cessation ⋅

On Target with Dr. Akila Viswanathan – Brain Cancer

October 22, 2019

In the next On Target podcast, Dr Akila Viswanathan speaks with Dr Lawrence Kleinberg about the treatment of brain cancer and engaging the immune system to combat tumors.

Clinton ⋅ Akila Viswanathan, brain cancer, immunotherapy, Johns Hopkins Kimmel Cancer Center, Lawrence Kleinberg, On Target, podcast ⋅

Meet Janice Paulshock: Twenty-Year Advanced Stage Ovarian Cancer Survivor

August 9, 2019

Janice Paulshock is a busy woman. The 58-year-old resident of Harford County, a Maryland suburb, works full-time; is a committed mother and grandmother; runs to keep in shape; participates in charity bike rides to raise money for multiple sclerosis, from which her husband suffers; and volunteers to support current patients and medical students at Johns […]

Clinton ⋅ Patient Stories BRCA2, Deborah Armstrong, immunotherapy, Janice Paulshock, Johns Hopkins Kimmel Cancer Center, Kelly Gynecological Oncology Service, Ovarian Cancer Research Alliance, PARP Inhibitors, Paula Silverman, Survivorship ⋅

Jaffee looks to the future of checkpoint immunotherapy for cancer treatment

January 28, 2019

Combinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important advances were also made with respect to immune-related biomarkers, cellular immunotherapies, and personalized vaccines. Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, is focusing her research […]

Larry Frum ⋅ Issues & Perspectives, Prevention/Screening Bloomberg~Kimmel Institute For Cancer Immunotherapy, Cancer Research Institute, checkpoint immunotherapy, Elizabeth Jaffee, immunotherapy, Johns Hopkins Kimmel Cancer Center, precision medicine, treatment, webinar ⋅